Exhibit 10.6
MAPLIGHT THERAPEUTICS, INC.
October 3, 2025
Vishwas Setia Via Email
Re: Confirmatory Offer Letter
Dear Vish,
You are currently employed by MapLight Therapeutics, Inc. (the "Company" or “MapLight”) as Chief Financial Officer. As discussed, this confirmatory offer letter (this “Agreement”) confirms the existing terms and conditions of your employment in that role and is intended to replace and supersede any previously executed agreement covering the subject matter herein, including but not limited to your Offer Letter dated January 30, 2024 (the “Prior Agreement”). This Agreement will be contingent upon approval of the MapLight Therapeutics, Inc. Severance and Change in Control Plan (the “Severance Plan”) by the Company’s Board of Directors and execution of the underwriting agreement between the Company and the underwriter(s) managing the initial public offering of the Company’s common stock, pursuant to which the common stock is priced for the initial public offering. This Agreement will be effective upon the IPO Date (as defined in the Severance Plan) (the “Effective Date”).
As of the Effective Date, your salary will be paid at the rate of USD $499,000 on an annualized basis (“Base Salary”), which will be paid in accordance with the Company's normal payroll procedures and subject to applicable payroll withholdings and deductions. Your salary is subject to review and adjustment by the Company in its sole discretion.
For the year ending December 31, 2025, you will continue to be eligible to receive an annual discretionary bonus award of up to thirty-five percent (35%) of your Base Salary, subject to applicable payroll withholdings and deductions. For the year ending December 31, 2026, you will be eligible to receive an annual discretionary bonus award of up to forty percent (40%) of your Base Salary, subject to applicable payroll withholdings and deductions. The bonus award, if any, will be determined by the Board of Directors or a Committee thereof in its sole discretion, based on achieving specific goals to be determined by the Board of Directors. To the extent that you earn any bonus hereunder, such bonus will be paid at the same time that bonuses are paid to other similarly-situated Company employees, but in no event later than forty-five (45) days following the end of the fiscal year in which it was earned. You must be an active employee of the Company on the date on which bonuses are distributed in order to be eligible for and to be deemed as having earned any bonus award.
As a full-time, regular employee of MapLight, you will remain eligible for Company benefits in accordance with the Company’s applicable benefit plans and policies for similarly-situated employees, subject to plan terms, generally-applicable Company policies, and any applicable waiting periods.

The Company may change your compensation and benefits from time to time in its discretion.



Vishwas Setia

MapLight Therapeutics, Inc.
By:
You acknowledge and agree that upon your execution of this Agreement, you will no longer be eligible for, nor entitled to, any compensation or benefits (including without limitation, any severance or change in control benefits) under any prior employment terms, offer letter or employment agreement you may have entered into or discussed with the Company, including but not limited to your Prior Agreement.
This Agreement, together with your Confidential Information Agreement, equity agreements, the Severance Plan and other agreements referenced herein, forms the complete and exclusive agreement regarding the subject matter hereof. It supersedes any other representations, promises, or agreements, whether written or oral, including the Prior Agreement. Modifications or amendments to this Agreement, other than those changes expressly reserved to the Company’s discretion herein, must be made in a written agreement signed by you and an officer of the Company (other than you).
If any provision of this Agreement is determined to be invalid or unenforceable, in whole or in part, this determination shall not affect any other provision of this Agreement and the provision in question shall be modified so as to be rendered enforceable in a manner consistent with the intent of the parties insofar as possible under applicable law. This letter may be delivered and executed via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other applicable law) or other transmission method and shall be deemed to have been duly and validly delivered and executed and be valid and effective for all purposes.
Please sign below and return this letter to me no later than October 3, 2025 to indicate your agreement with its terms.
Very truly yours,
Christopher A. Kroeger, M.D. President and Chief Executive Officer
I have read and accept these terms of employment.
October 3, 2025
DATE